Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats

Previous studies have suggested that the sodium alginate (SA) is beneficial for the treatment of non-alcoholic fatty liver disease (NAFLD), while the potential mechanisms are largely unknown. The present study aimed to clarify the effects and potential mechanisms of SA in preventing NAFLD via the gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hui, Gao, Xiang, Liu, Zhizuo, Zhang, Lei, Fang, Xuan, Sun, Jianping, Zhang, Zhaofeng, Sun, Yongye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697635/
https://www.ncbi.nlm.nih.gov/pubmed/36432531
http://dx.doi.org/10.3390/nu14224846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697635/
https://www.ncbi.nlm.nih.gov/pubmed/36432531
http://dx.doi.org/10.3390/nu14224846

Ejemplares similares